|
Is it COVID-19 or Is It Heart Failure: Management of Ambulatory Heart Failure Patients - April 1, 2020
Watch webinar #2 now - The CCS COVID-19 Rapid Response Team presents: Cardiovascular Considerations & Treatment Tips for Patients with COVID-19
Reducing in-hospital spread and the optimal use of resources for the care of hospitalized cardiovascular patients during the COVID-19 pandemic - March 30, 2020
Watch webinar #1 now – COVID-19 & the Cardiovascular Patient: Practical advice for implementing recommendation from the CCS COVID-19 Rapid Response Team
Guidance on Community-based Care of the Cardiovascular Patient During the COVID-19 Pandemic - March 25, 2020
COVID-19 and Cardiovascular Disease: What the Cardiac Healthcare Provider Should Know - March 22, 2020
Updated - COVID-19 and concerns regarding use of cardiovascular medications, including ACEi/ARB/ARNi, low-dose ASA and non-steroidal anti-inflammatory drugs (NSAIDS) - March 20, 2020
Guidance on hospital-based care and cardiac procedures during the COVID-19 crisis - March 19, 2020
Joint letter to the Deputy Ministers of Health and Public Safety offering expert guidance on a coordinated strategy regarding the use of ECMO during the COVID-19 pandemic - March 17, 2020
Guidance on ambulatory management and diagnostic testing during the COVID-19 crisis - March 17, 2020
COVID-19 and cardiac device patients: A message from the Canadian Heart Rhythm Society – March 16, 2020
COVID-19 and use of ACEi/ARB/ARNi medications for heart failure or hypertension – March 15, 2020
CCS’s response to the COVID-19 pandemic – March 15, 2020
|
